This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Oncology
Yescarta approved by NICE for relapsed/remitted lymphomas
Read more
T cell biomarker predicts CAR T cell therapy response in relapsed lymphoma
Read more
CTX-009 shows promise in biliary tract cancer
Read more
Infusion of novel agent reduces oral mucositis following chemoradiotherapy
Read more
Contrast-enhanced CT enables prediction of treatment response in liver cancer
Read more
MRI-guided stereotactic radiotherapy superior to CT in prostate cancer
Read more
Cone beam breast CT superior to MRI for detection of preoperative residual tumour
Read more
Talquetamab effective in relapsed/refractory multiple myeloma
Read more
Anti-CD20 therapy increases complication risk in COVID-19 for blood cancer patients
Read more
Glofitamab fast and effective in refractory mantle cell lymphoma
Read more
CHMP recommends Enhertu for HER2-low breast cancer treatment
Read more
Elranatamab induces durable clinical response in relapsed multiple myeloma
Read more
mRNA-4157/V940 vaccine effective in advanced melanoma
Read more
Cannabidiol of no additional value for symptom distress reduction in advanced cancer
Read more
Zanubrutinib improves progression-free survival in relapsed lymphocytic leukaemia
Read more
Tafasitamab shows best efficacy in refractory diffuse large B-cell lymphoma
Read more
Medical marijuana reduces opiate use among cancer patients
Read more
Page 8 of 40
« First
«
...
6
7
8
9
10
...
20
30
40
...
»
Last »
Popular articles
New protocol for IBD referral triage reduces diagnostic delays, say researchers
24 April, 2024
Semaglutide shows promise in patients with type 2 diabetes and obesity-related heart failure
22 April, 2024
Ivacaftor use in cystic fibrosis ‘safe and effective’ from one month old, study finds
25 April, 2024
x
Search for: